Global Occlusion Devices Market – Industry Analysis and Forecast (2017 To 2024) By Product, Application, End Use and Region.

Global Occlusion Devices Market – Industry Analysis and Forecast (2017 To 2024) By Product, Application, End Use and Region.

Market Scenario

Global Occlusion Devices Market was valued at USD2.65 billion in 2017 and is estimated to grow at a CAGR of 5.5% from 2017 to 2024. Global Occlusion Devices Market Occlusion device is a technology equivalent to the treatment of different cardiovascular defects, neurological defects, retinal defects, and others. These occlusion devices are adapted to treat occlusion which is medically referred to as the blockage or closing of the blood vessels or any hollow organs. Some of the Global Occlusion Devices Market drivers include the increasing target patient population, technological advancements, favourable reimbursement scenario for minimally invasive surgeries, availability of clinical evidence for the safety and efficacy of occlusion procedures, changing technology and innovation, rising prevalence of cancer, changing demographics and lifestyles leading to an increased prevalence of peripheral vascular diseases, adoption of new products, rising demand for advanced medical instruments, geriatric population. Global Occlusion Devices Market is segmented by product, application, end user, and region Global Occlusion Devices have the largest usage in clinics, hospitals, Research Laboratories & Academic Institutes. Geographically, global occlusion devices Global Occlusion Devices Market is classified into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2018, North America is anticipated to account the largest share in the Global Occlusion Devices Market. The sizable share of the North American market can primarily be attributed to the high prevalence of auspicious reimbursement scenario for minimally invasive surgeries, availability of clinical evidence for the safety and efficacy of occlusion procedures, transmuting technology and innovation. Asia Pacific market is expected to grow at the fastest rate during the forecast period owing to the increasing demand for global occlusion devices. Many minuscule players are looking forward to investing in the Asia Pacific market due to a sizable patient pool and the incremental utilization of occlusion devices. The key players in the Global Occlusion Devices Market include Cook Group, Stryker Corporation, Medtronic, Boston Scientific, Cardinal Health, Terumo, Penumbra, Abbott, B. Braun, Asahi Intecc, C.R. Bard, Angiodynamics, and Acrostak. The years that have been considered for the study are: • Base year – 2016 • Estimated year – 2017 • Forecast period – 2017 to 2024

Global Occlusion Devices Market - Key Segment:

Global Occlusion Devices Market, By Product

• Occlusion Removal Devices o Balloon Occlusion Devices o Stent Retrievers o Coil Retrievers o Suction & Aspiration Devices • Embolization Devices o Embolic Coils o Liquid Embolic Agents o Tubal Occlusion Devices • Support Devices o Microcatheters o Guidewires

Global Occlusion Devices Market, By Application

• Neurology • Cardiology • Peripheral Vascular Diseases • Urology • Oncology • Gynecology

Global Occlusion Devices Market, By End User

• Hospitals, Diagnostic Centers, & Surgical Centers • Ambulatory Care Centers • Research Laboratories & Academic Institutes Top Market competitors/players: • Terumo Corporation, • Medtronic, Inc., • Boston Scientific Corporation • Stryker Corporation, • Cordis Corporation, • DePuy Synthes; • St. Jude Medical, • Cook Medical, • Sirtex medical, • Nordian, • Penumbra, • Abbott, • Cardinal Health, • B. Braun, • Asahi Intecc, • C.R. Bard, • Cook Group, • Angiodynamics, • Acrostak • Among others.

Global Occlusion Devices Market, By Region

North America • U.S • Canada Europe • Germany • France • UK • Italy • Spain • Russia • Rest of Europe Asia Pacific • Japan • China • India • South Korea • Australia • Rest of Asia Pacific Rest of the World (ROW): • Middle-East • Africa • Latin America Research Methodology: Global Occlusion Devices Market is estimated by analyzing the data points obtained from various sources and conducting them into a predictor model created specifically for each individual market. The data points are extracted from paid and unpaid sources along with paid primary interviews with key opinion leaders in the market. Key opinion leaders from both demand and supply sides of the market were considered while conducting interviews to get an unbiased idea of the Global Occlusion Devices Market. This exercise was done at a country level to get a fair idea of the market in countries considered for this analysis. This country-specific analysis was accumulated to establish regional numbers and then arrive at the global market value for Global Occlusion Devices Market. Global Vascular Patches Devices Market

Table of Contents

Global Occlusion Devices Market

1. INTRODUCTION 1.1. Market description & Scope (2016-2024) 1.2. Objectives 1.2.1. Key Takeaways 1.2.2. Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1. Methods used for market forecasting 2.2. Data 2.2.1. Paid 2.2.2. Primary 2.2.3. Secondary 3. EXECUTIVE SUMMARY 3.1. Major Findings 3.1.1. Key Segment Trends 3.1.1.1. Product 3.1.1.2. Application 3.1.1.3. End User 3.1.2. Key Regional Trends 3.1.2.1. North America 3.1.2.2. Europe 3.1.2.3. Asia Pacific 3.1.2.4. Rest of the World 3.2. Key Companies and their Strategies 4. MARKET OVERVIEW 4.1. Global Occlusion Devices Concept & Definition 4.2. Segments Overview 4.2.1. By product 4.2.1.1. Occlusion Removal Devices 4.2.1.1.1. Balloon Occlusion Devices 4.2.1.1.2. Stent Retrievers 4.2.1.1.3. Coil Retrievers 4.2.1.1.4. Suction & Aspiration devices 4.2.1.2. Embolization Devices 4.2.1.2.1. Embolic Coils 4.2.1.2.2. Liquid Embolic Agents 4.2.1.2.3. Tubal Occlusion Devices 4.2.1.3. Support Devices 4.2.1.3.1. Microcatheters 4.2.1.3.2. Guidewires 4.2.2. By Application 4.2.2.1.1. Neurology 4.2.2.1.2. Cardiology 4.2.2.1.3. Peripheral Vascular Diseases 4.2.2.1.4. Urology 4.2.2.1.5. Oncology 4.2.2.1.6. Gynecology 4.2.3. By End User 4.2.3.1. Hospitals, Diagnostic Centers, & Surgical Centers 4.2.3.2. Ambulatory Care Centers 4.2.3.3. Research Laboratories & Academic Institutes 4.2.4. Market Dynamics 4.2.4.1. Drivers 4.2.4.2. Restraints 4.2.4.3. Opportunities 4.3. Porter’s Analysis 4.4. PESTLE Analysis 4.5. Fragmentation 4.5.1. Key strategic Alliances of companies (inorganic & organic) 4.5.2. Company Market Share (Top 10 Players) 4.5.3. Comparative Analysis of Key players in Recycled Plastics 4.6. Key Trends 4.7. Key Trends in Global Occlusion Devices Market 5. GLOBAL OCCLUSION DEVICES PRODUCT & TREND ANALYSIS (2016 – 2024) 5.1. Global Occlusion Devices Market Product Analysis 5.1.1. Occlusion Removal Devices 5.1.1.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 5.1.2. Embolization Devices 5.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 5.1.3. Support Devices 5.1.3.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 5.2. Global Occlusion Devices Market: Product Trends 6. GLOBAL OCCLUSION DEVICES APPLICATION & TREND ANALYSIS (2016 – 2024) 6.1. Global Occlusion Devices Application Market Analysis 6.1.1.1. Neurology 6.1.1.1.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.1.1.2. Cardiology 6.1.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.1.1.3. Peripheral Vascular 6.1.1.3.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.1.1.4. Urology 6.1.1.4.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.1.1.5. Oncology 6.1.1.5.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.1.1.6. Gynecology 6.1.1.6.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 6.2. Global Occlusion Devices Market: Application Trends 7. GLOBAL OCCLUSION DEVICES END USER & TREND ANALYSIS (2016 – 2024) 7.1. Global Occlusion Devices End User Market Analysis 7.1.1. Hospitals 7.1.1.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 7.1.2. Ambulatory Surgical Centers 7.1.2.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 7.2. Research Laboratories & Academic Institutes 7.2.1.1.1. Market Share and growth forecasts, 2016 – 2024 (USD Billion) 7.3. Global Occlusion Devices Market: End-user Trends 8. REGIONAL ESTIMATES & TREND ANALYSIS (2016 – 2024) 8.1. Global Occlusion Devices market share by Region, 2016 & 2025 8.2. North America 8.2.1. North America Global Occlusion Devices market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 8.2.2. Global Occlusion Devices Drivers For North America Market 8.2.3. Market Share Analysis and Growth Forecast, by Country 8.2.3.1. US 8.2.3.2. Canada 8.2.4. Country-wise GDP Growth Forecast 8.2.5. Global Occlusion Devices Trends In North America Market 8.3. Europe 8.3.1. Europe Global Occlusion Devices market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 8.3.2. Global Occlusion Devices Drivers For Europe Market 8.3.3. Market Share Analysis and Growth Forecast, by Country 8.3.3.1. UK 8.3.3.2. Germany 8.3.3.3. France 8.3.3.4. Russia 8.3.3.5. Spain 8.3.3.6. Italy 8.3.3.7. Others 8.3.4. Country-wise GDP Growth Forecast 8.3.5. Global Occlusion Devices Trends In Europe Market 8.4. Asia Pacific 8.4.1. Asia Pacific Global Occlusion Devices market, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 8.4.2. Global Occlusion Devices Drivers For Asia Pacific Market 8.4.3. Market Share Analysis and Growth Forecast, by Country 8.4.3.1. China 8.4.3.2. Japan 8.4.3.3. India 8.4.3.4. South Korea 8.4.3.5. Australia 8.4.3.6. Others 8.4.4. Country-wise GDP Growth Forecast 8.4.5. Global Occlusion Devices Trends In Asia Pacific Market 8.5. Rest of the World 8.5.1. Rest of the World Wound Care Biologics Device Smarket, Market Share and growth forecasts, 2016 – 2024 (USD Billion) 8.5.2. Global Occlusion Devices Drivers For Rest of the World Market 8.5.3. Market Share Analysis and Growth Forecast, by Country 8.5.3.1. Middle-East 8.5.3.2. Africa 8.5.3.3. Latin America 8.5.4. Country-wise GDP Growth Forecast 8.5.5. Global Occlusion Devices Trends In Rest of the World Market 9. MARKET SHARE ANALYSIS 9.1. Key Players Regional Market share Analysis 9.1.1. North America 9.1.2. Europe 9.1.3. Asia Pacific 9.1.4. Middle-east 9.1.5. Latin America 10. MARKET COMPETITION ANALYSIS 10.1. Strategy Framework 10.2. Consolidation 10.2.1. Patent Analysis 10.2.2. Mergers & Acquisitions 10.2.2.1. Product Based 10.2.2.2. Services Based 10.2.2.3. Region Based 10.2.2.4. List of Mergers & Acquisitions 10.2.3. Company Benchmarking (Revenue & Profit Based) 10.2.4. Strategic Assessment of Company Consolidations 10.2.5. Emerging Business Models 10.3. Company Profiles 10.3.1. Terumo Corporation 10.3.1.1. Company overview 10.3.1.2. Key financials 10.3.1.3. Geographical presence 10.3.1.4. Product and Business Segments 10.3.1.5. Strategic initiatives 10.3.1.6. SWOT analysis 10.3.1.7. Competitive positioning and landscape 10.3.2. Medtronic, Inc., 10.3.2.1. Company overview 10.3.2.2. Key financials 10.3.2.3. Geographical presence 10.3.2.4. Product and Business Segments 10.3.2.5. Strategic initiatives 10.3.2.6. SWOT analysis 10.3.2.7. Competitive positioning and landscape 10.3.3. Boston Scientific Corporation 10.3.3.1. Company overview 10.3.3.2. Key financials 10.3.3.3. Geographical presence 10.3.3.4. Product and Business Segments 10.3.3.5. Strategic initiatives 10.3.3.6. SWOT analysis 10.3.3.7. Competitive positioning and landscape 10.3.4. Stryker Corporation 10.3.4.1. Company overview 10.3.4.2. Key financials 10.3.4.3. Geographical presence 10.3.4.4. Product and Business Segments 10.3.4.5. Strategic initiatives 10.3.4.6. SWOT analysis 10.3.4.7. Competitive positioning and landscape 10.3.5. Cordis Corporation 10.3.5.1. Company overview 10.3.5.2. Key financials 10.3.5.3. Geographical presence 10.3.5.4. Product and Business Segments 10.3.5.5. Strategic initiatives 10.3.5.6. SWOT analysis 10.3.5.7. Competitive positioning and landscape 10.3.6. Depuy Synthes 10.3.6.1. Company overview 10.3.6.2. Key financials 10.3.6.3. Geographical presence 10.3.6.4. Product and Business Segments 10.3.6.5. Strategic initiatives 10.3.6.6. SWOT analysis 10.3.6.7. Competitive positioning and landscape 10.3.7. St. Jude Medical 10.3.7.1. Company overview 10.3.7.2. Key financials 10.3.7.3. Geographical presence 10.3.7.4. Product and Business Segments 10.3.7.5. Strategic initiatives 10.3.7.6. SWOT analysis 10.3.7.7. Competitive positioning and landscape 10.3.8. Cook Medical 10.3.8.1. Company overview 10.3.8.2. Key financials 10.3.8.3. Geographical presence 10.3.8.4. Product and Business Segments 10.3.8.5. Strategic initiatives 10.3.8.6. SWOT analysis 10.3.8.7. Competitive positioning and landscape 10.3.9. Sirtex Medical 10.3.9.1. Company overview 10.3.9.2. Key financials 10.3.9.3. Geographical presence 10.3.9.4. Product and Business Segments 10.3.9.5. Strategic initiatives 10.3.9.6. SWOT analysis 10.3.9.7. Competitive positioning and landscape 10.3.10. Nordian 10.3.10.1. Company overview 10.3.10.2. Key financials 10.3.10.3. Geographical presence 10.3.10.4. Product and Business Segments 10.3.10.5. Strategic initiatives 10.3.10.6. SWOT analysis 10.3.10.7. Competitive positioning and landscape 10.3.11. Penumbra 10.3.11.1. Company overview 10.3.11.2. Key financials 10.3.11.3. Geographical presence 10.3.11.4. Product and Business Segments 10.3.11.5. Strategic initiatives 10.3.11.6. SWOT analysis 10.3.11.7. Competitive positioning and landscape 10.3.12. Abbott 10.3.12.1. Company overview 10.3.12.2. Key financials 10.3.12.3. Geographical presence 10.3.12.4. Product and Business Segments 10.3.12.5. Strategic initiatives 10.3.12.6. SWOT analysis 10.3.12.7. Competitive positioning and landscape 10.3.13. Cardinal Health 10.3.13.1. Company overview 10.3.13.2. Key financials 10.3.13.3. Geographical presence 10.3.13.4. Product and Business Segments 10.3.13.5. Strategic initiatives 10.3.13.6. SWOT analysis 10.3.13.7. Competitive positioning and landscape 10.3.14. B. Braun 10.3.14.1. Company overview 10.3.14.2. Key financials 10.3.14.3. Geographical presence 10.3.14.4. Product and Business Segments 10.3.14.5. Strategic initiatives 10.3.14.6. SWOT analysis 10.3.14.7. Competitive positioning and landscape 10.3.15. Asahi Intecc 10.3.15.1. Company overview 10.3.15.2. Key financials 10.3.15.3. Geographical presence 10.3.15.4. Product and Business Segments 10.3.15.5. Strategic initiatives 10.3.15.6. SWOT analysis 10.3.15.7. Competitive positioning and landscape 10.3.16. C.R. Bard 10.3.16.1. Company overview 10.3.16.2. Key financials 10.3.16.3. Geographical presence 10.3.16.4. Product and Business Segments 10.3.16.5. Strategic initiatives 10.3.16.6. SWOT analysis 10.3.16.7. Competitive positioning and landscape 10.3.17. Cook Group 10.3.17.1. Company overview 10.3.17.2. Key financials 10.3.17.3. Geographical presence 10.3.17.4. Product and Business Segments 10.3.17.5. Strategic initiatives 10.3.17.6. SWOT analysis 10.3.17.7. Competitive positioning and landscape 10.3.18. Angiodynamics 10.3.18.1. Company overview 10.3.18.2. Key financials 10.3.18.3. Geographical presence 10.3.18.4. Product and Business Segments 10.3.18.5. Strategic initiatives 10.3.18.6. SWOT analysis 10.3.18.7. Competitive positioning and landscape 10.3.19. Acrostak 10.3.19.1. Company overview 10.3.19.2. Key financials 10.3.19.3. Geographical presence 10.3.19.4. Product and Business Segments 10.3.19.5. Strategic initiatives 10.3.19.6. SWOT analysis 10.3.19.7. Competitive positioning and landscape

About This Report

Report ID10985
Published Date
Contact Us
Call Now